• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿仑膦酸钠长期治疗增加了霍兹曼大鼠简单拔牙术中的手术难度 - 一项体内观察。

Long-term treatment with alendronate increases the surgical difficulty during simple exodontias - an in vivo observation in Holtzman rats.

机构信息

Department of Diagnosis and Surgery, Division of Periodontology, UNESP- Univ, Estadual Paulista, School of Dentistry, Rua Humaitá, 1680, Araraquara, SP, 14801-903, Brazil.

出版信息

Head Face Med. 2012 Jul 26;8:20. doi: 10.1186/1746-160X-8-20.

DOI:10.1186/1746-160X-8-20
PMID:22834876
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3489782/
Abstract

BACKGROUND

Atraumatic teeth extractions protocols are highly encouraged in patients taking bisphosphonates (Bps) to reduce surgical trauma and, consequently, the risk of jaws osteonecrosis development. In this way, this paper aims to report the findings of increased surgical difficulty during simple exodontias in animals treated with bisphosphonates.

METHODS

Sixty male Holtzman rats were randomly distributed into three groups of 20 animals and received daily subcutaneous administration of 1 mg/kg (AL1) or 3 mg/kg (AL3) of alendronate or saline solution (CTL). After 60 days of drug therapy all animals were submitted to first lower molars extractions under general anesthesia. Operatory surgical time and the frequency of teeth fractures were measured as principal outcomes and indicators of surgical difficulty degree.

RESULTS

Animals treated with alendronate (AL1 and AL3) were associated to higher operatory times and increased frequency of teeth fractures compared to match controls.

CONCLUSIONS

The bisphosphonate therapy may be associated with an increased surgical difficulty and trauma following simple exodontias protocols, which is considered a critical issue when it comes to osteonecrosis development.

摘要

背景

为了降低手术创伤,进而降低颌骨坏死发展风险,接受双膦酸盐(Bps)治疗的患者强烈推荐采用微创拔牙术。因此,本文旨在报告在接受双膦酸盐治疗的动物中,微创拔牙术时手术难度增加的发现。

方法

60 只雄性霍尔茨曼大鼠随机分为三组,每组 20 只,每天接受 1mg/kg(AL1)或 3mg/kg(AL3)的阿仑膦酸钠或生理盐水(CTL)的皮下注射。药物治疗 60 天后,所有动物均在全身麻醉下进行下颌第一磨牙拔除术。主要观察指标为手术操作时间和牙齿骨折的频率,以评估手术难度。

结果

与匹配对照组相比,接受阿仑膦酸钠(AL1 和 AL3)治疗的动物手术时间更长,牙齿骨折的频率更高。

结论

双膦酸盐治疗可能与微创拔牙术后手术难度增加和创伤增加相关,这在颌骨坏死发展方面是一个关键问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f372/3489782/8164e7eff4f7/1746-160X-8-20-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f372/3489782/c6d3c27154f4/1746-160X-8-20-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f372/3489782/8164e7eff4f7/1746-160X-8-20-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f372/3489782/c6d3c27154f4/1746-160X-8-20-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f372/3489782/8164e7eff4f7/1746-160X-8-20-2.jpg

相似文献

1
Long-term treatment with alendronate increases the surgical difficulty during simple exodontias - an in vivo observation in Holtzman rats.阿仑膦酸钠长期治疗增加了霍兹曼大鼠简单拔牙术中的手术难度 - 一项体内观察。
Head Face Med. 2012 Jul 26;8:20. doi: 10.1186/1746-160X-8-20.
2
Tooth extraction in osteoporotic patients taking oral bisphosphonates.骨质疏松症患者服用口服双膦酸盐时拔牙。
Osteoporos Int. 2013 May;24(5):1707-12. doi: 10.1007/s00198-012-2239-8. Epub 2013 Jan 4.
3
The influence of alendronate and tooth extraction on the incidence of osteonecrosis of the jaw among osteoporotic subjects.阿仑膦酸盐和拔牙对骨质疏松患者颌骨坏死发生率的影响。
PLoS One. 2018 Apr 25;13(4):e0196419. doi: 10.1371/journal.pone.0196419. eCollection 2018.
4
Bisphosphonate-induced osteonecrosis of the jaw in a rat model arises first after the bone has become exposed. No primary necrosis in unexposed bone.在大鼠模型中,双膦酸盐诱导的下颌骨坏死首先发生在骨暴露之后。未暴露的骨中没有原发性坏死。
J Oral Pathol Med. 2012 Jul;41(6):494-9. doi: 10.1111/j.1600-0714.2011.01125.x. Epub 2012 Jan 23.
5
Bisphosphonate-Related Osteonecrosis of the Jaw After Tooth Extraction.拔牙后双膦酸盐相关颌骨坏死
J Craniofac Surg. 2015 Oct;26(7):e606-8. doi: 10.1097/SCS.0000000000002051.
6
Atypical femoral fractures shortly after osteonecrosis of the jaw in a postmenopausal woman taking alendronate for osteoporosis.绝经后妇女在服用阿仑膦酸钠治疗骨质疏松症后不久发生颌骨骨坏死和典型股骨骨折。
J Clin Endocrinol Metab. 2013 Apr;98(4):E723-6. doi: 10.1210/jc.2012-4144. Epub 2013 Mar 7.
7
Experimental osteonecrosis: development of a model in rodents administered alendronate.实验性骨坏死:在给予阿仑膦酸钠的啮齿动物中建立模型
Braz Oral Res. 2016 Aug 22;30(1):e99. doi: 10.1590/1807-3107BOR-2016.vol30.0099.
8
Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws.C末端交联端肽检测在双膦酸盐相关颌骨骨坏死防治中的临床研究
J Oral Maxillofac Surg. 2009 Jun;67(6):1167-73. doi: 10.1016/j.joms.2009.02.004.
9
Diabetes mellitus and corticotherapy as risk factors for alendronate-related osteonecrosis of the jaws: a study in Wistar rats.糖尿病和皮质激素治疗作为导致阿仑膦酸钠相关性颌骨坏死的危险因素:一项 Wistar 大鼠研究。
Head Neck. 2014 Jan;36(1):84-93. doi: 10.1002/hed.23260. Epub 2013 May 4.
10
Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.双膦酸盐导致的颌骨暴露性骨病变(骨坏死/骨硬化症):危险因素、识别、预防及治疗
J Oral Maxillofac Surg. 2005 Nov;63(11):1567-75. doi: 10.1016/j.joms.2005.07.010.

本文引用的文献

1
Treatment for a complicated crown-root fracture with intentional replantation: a case report with a 3.5-year follow up.复杂冠根折伴即刻再植的治疗:一例3.5年随访的病例报告
Dent Traumatol. 2013 Dec;29(6):474-8. doi: 10.1111/j.1600-9657.2012.01130.x. Epub 2012 Mar 27.
2
Risk indicators of postoperative complications following surgical extraction of lower third molars.下颌第三磨牙拔除术后并发症的风险指标。
Med Princ Pract. 2011;20(4):321-5. doi: 10.1159/000324550. Epub 2011 May 11.
3
Preventive protocol for tooth extractions in patients treated with zoledronate: a case series.
唑来膦酸盐治疗患者拔牙的预防方案:病例系列
J Oral Maxillofac Surg. 2011 Jun;69(6):e1-4. doi: 10.1016/j.joms.2010.10.055. Epub 2011 Apr 2.
4
Initial experience on the outcome of teeth extractions in intravenous bisphosphonate-treated patients: a cautionary report.静脉注射双膦酸盐治疗患者拔牙结局的初步经验:一份警示报告。
J Oral Maxillofac Surg. 2011 Feb;69(2):456-62. doi: 10.1016/j.joms.2010.07.026. Epub 2010 Dec 3.
5
Radiographic findings in bisphosphonate-treated patients with stage 0 disease in the absence of bone exposure.在无骨暴露的0期疾病双膦酸盐治疗患者中的影像学表现。
J Oral Maxillofac Surg. 2010 Sep;68(9):2232-40. doi: 10.1016/j.joms.2010.05.003.
6
Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients.双膦酸盐相关颌骨坏死:26例患者的临床特征、危险因素、管理及治疗结果
J Oral Maxillofac Surg. 2009 Sep;67(9):1904-13. doi: 10.1016/j.joms.2009.04.051.
7
Bisphosphonate-associated osteonecrosis of the jaw: a key role of inflammation?双膦酸盐相关颌骨坏死:炎症起关键作用?
Bone. 2009 Nov;45(5):843-52. doi: 10.1016/j.bone.2009.07.011. Epub 2009 Jul 22.
8
The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data.双膦酸盐相关颌骨坏死的发病机制:假说众多,数据匮乏。
J Oral Maxillofac Surg. 2009 May;67(5 Suppl):61-70. doi: 10.1016/j.joms.2009.01.007.
9
Dental panoramic radiographic evaluation in bisphosphonate-associated osteonecrosis of the jaws.双膦酸盐相关颌骨骨坏死的牙科全景X线片评估
Oral Dis. 2009 Jan;15(1):88-92. doi: 10.1111/j.1601-0825.2008.01494.x. Epub 2008 Sep 26.
10
Complications of third molar surgery.第三磨牙手术的并发症。
Oral Maxillofac Surg Clin North Am. 2007 Feb;19(1):117-28, vii. doi: 10.1016/j.coms.2006.11.013.